Trial intelligence / Profile preview

Praziquantel versus mebendazole for treatment of giardiasis

IRCT138708131431N1Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
May 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of praziquantel and mebendazole in giardiasis (2 arms), sponsored by Shahrekord University of Medical Sciences. Started May 2008; status: completed.

02

Drugs

praziquantelmebendazole
03

Conditions

giardiasis

Beyond the preview

Go deeper on IRCT138708131431N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT138708131431N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call